HF Advisory Group LLC Boosts Holdings in Sanofi (NASDAQ:SNY)

HF Advisory Group LLC raised its holdings in Sanofi (NASDAQ:SNY) by 7.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 30,812 shares of the company’s stock after buying an additional 2,049 shares during the quarter. HF Advisory Group LLC’s holdings in Sanofi were worth $1,486,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in SNY. Northwest Investment Counselors LLC bought a new position in shares of Sanofi in the 3rd quarter worth about $29,000. Concord Wealth Partners grew its holdings in Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock worth $34,000 after purchasing an additional 363 shares during the period. Fortitude Family Office LLC grew its stake in shares of Sanofi by 708.6% in the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after acquiring an additional 659 shares during the last quarter. Sunbelt Securities Inc. increased its holdings in shares of Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after acquiring an additional 313 shares in the last quarter. Finally, Versant Capital Management Inc purchased a new position in shares of Sanofi in the 4th quarter worth about $54,000. 14.04% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $57.50.

Sanofi Stock Performance

Shares of NASDAQ SNY opened at $50.74 on Friday. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The firm’s 50-day moving average price is $48.46 and its 200-day moving average price is $52.09. Sanofi has a 52-week low of $45.22 and a 52-week high of $58.97. The company has a market cap of $128.77 billion, a PE ratio of 25.89, a PEG ratio of 1.17 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last posted its earnings results on Friday, October 25th. The company reported $1.57 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $1.35. The business had revenue of $13.44 billion during the quarter, compared to the consensus estimate of $16.59 billion. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. The firm’s revenue was up 12.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.55 EPS. As a group, analysts anticipate that Sanofi will post 3.94 EPS for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.